118 related articles for article (PubMed ID: 8874202)
41. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
42. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
Krzystyniak K; Panaye G; Descotes J; Revillard JP
Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
[TBL] [Abstract][Full Text] [Related]
43. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.
Cooke KR; Krenger W; Hill G; Martin TR; Kobzik L; Brewer J; Simmons R; Crawford JM; van den Brink MR; Ferrara JL
Blood; 1998 Oct; 92(7):2571-80. PubMed ID: 9746799
[TBL] [Abstract][Full Text] [Related]
44. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
Martin PJ
J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
[TBL] [Abstract][Full Text] [Related]
45. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
46. Effect of deoxyspergualin on graft-versus-host disease and graft- versus-leukemia in mice.
Weiss L; Reich S; Slavin S
Bone Marrow Transplant; 1996 May; 17(5):789-92. PubMed ID: 8733699
[TBL] [Abstract][Full Text] [Related]
47. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.
Fujii H; Ivison SM; Shimizu H; Kajiwara R; Kariminia A; Yan M; Dutz JP; Schultz KR
Biol Blood Marrow Transplant; 2012 Apr; 18(4):546-56. PubMed ID: 22178962
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.
Wu Y; Heinrichs J; Bastian D; Fu J; Nguyen H; Schutt S; Liu Y; Jin J; Liu C; Li QJ; Xia C; Yu XZ
Blood; 2015 Sep; 126(11):1314-23. PubMed ID: 26138686
[TBL] [Abstract][Full Text] [Related]
50. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
51. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
52. Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood.
de La Selle V; Gluckman E; Bruley-Rosset M
Blood; 1998 Nov; 92(10):3968-75. PubMed ID: 9808591
[TBL] [Abstract][Full Text] [Related]
53. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
[TBL] [Abstract][Full Text] [Related]
54. Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models.
Vourka-Karussis U; Ackerstein A; Pugatsch T; Slavin S
Exp Hematol; 1999 Mar; 27(3):461-9. PubMed ID: 10089908
[TBL] [Abstract][Full Text] [Related]
55. Infusion of select leukemia-reactive TCR Vbeta+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation.
Patterson AE; Korngold R
Biol Blood Marrow Transplant; 2001; 7(4):187-96. PubMed ID: 11349805
[TBL] [Abstract][Full Text] [Related]
56. T-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens.
DiRienzo CG; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2007 Mar; 13(3):265-76. PubMed ID: 17317580
[TBL] [Abstract][Full Text] [Related]
57. Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses.
Korngold R; Marini JC; de Baca ME; Murphy GF; Giles-Komar J
Biol Blood Marrow Transplant; 2003 May; 9(5):292-303. PubMed ID: 12766879
[TBL] [Abstract][Full Text] [Related]
58. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
[TBL] [Abstract][Full Text] [Related]
59. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.
Waller EK; Ship AM; Mittelstaedt S; Murray TW; Carter R; Kakhniashvili I; Lonial S; Holden JT; Boyer MW
Blood; 1999 Nov; 94(9):3222-33. PubMed ID: 10556211
[TBL] [Abstract][Full Text] [Related]
60. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
